PCM
RDHL

Penserra Capital Management’s Redhill Biopharma RDHL Stock Holding History

Penserra Capital Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$4K – 1514
2021
Q3 		$4K Hold
1
– – ﹤0.01% 1423
2021
Q2 		$7K Hold
1
– – ﹤0.01% 1297
2021
Q1 		$6K Hold
1
– – ﹤0.01% 1079
2020
Q4 		$6K Buy
+1
New +$8.99K ﹤0.01% 974
2017
Q2 		– Sell
-18
Closed -$171K – 569
2017
Q1 		$171K Buy
18
+8
+80% +$79.9K 0.02% 236
2016
Q4 		$106K Buy
+10
New +$120K 0.01% 323

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Penserra Capital Management's RDHL Position: Q4 2021 in Review

Penserra Capital Management sold out of Redhill Biopharma (RDHL) in Q4 2021, closing a stake of 1 share — an estimated $4K sold.

Penserra Capital Management first reported a position in RDHL in Q4 2016 and held it in 6 quarters. The position peaked at $171K in Q1 2017. 51 funds tracked by Wall St. Rank hold RDHL as of Q4 2021.

  • Penserra Capital Management reported no remaining Redhill Biopharma position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1 Redhill Biopharma share in Q4 2021, an estimated $4K.
  • Penserra Capital Management first reported a position in Redhill Biopharma in Q4 2016 and held it in 6 quarters.
  • Penserra Capital Management's Redhill Biopharma position peaked at $171K in Q1 2017.
  • 51 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.